CELLphenomics GmbH

Sarcomas comprise a relatively rare class of cancers, with about 4,000 new cases in Germany each year. Together with our colleagues at Helios Klinikum Berlin-Buch GmbH and ASC Oncology GmbH we research how therapies can be tailored even more precisely to the individual patient. Read the story here: https://lnkd.in/d--h3Mz Helios Kliniken GmbH Manuela Regenbrecht Jürgen Loskutov Maya Niethard #cancer #research #rethinkoncology #360degreesmedicine #sarcoma #carcinoma #PD3D® #ReverseClinicalEngineering

I am happy to share with you our latest publication together with our colleagues from Universitätsmedizin Göttingen https://lnkd.in/eGFXgNKu Although this is only a review article I am particularly proud of what we have to share: There are literally no relevant #invitro models 🧫 for thymomas available. In 2D those cells lose their proteasome, which is key for thymic cells and subsequent tumors and therefore useless for understanding the biology of thymomas. At ASC Oncology GmbH and CELLphenomics GmbH we now have 3 confirmed thymoma models available in our biobank, showing that with our expertise even these hard to grow tumors are within reach (original publication expected to come out soon). Especially for such rare tumors this will be an invaluable resource for researchers world-wide🌍. Within the German thymoma community word spread like lightning and we now receive thymoma tissue for #ReverseClinicalEngineering from Universitätsklinikum Regensburg, Universitätsmedizin Göttingen, and Charité - Universitätsmedizin Berlin.

Kürzlich hatte ich das Vergnügen, mit Kai Wiedermann von der FUNKE Mediengruppe über den Einsatz von Patienten-abgeleiteten Tumormodellen in der Behandlung von Krebspatienten zu sprechen. Was wir bei ASC Oncology GmbH und CELLphenomics GmbH für den Fortschritt der Onkologie tun und was ich zu dem Thema zu sagen habe, könnt ihr zB im Hamburger Abendblatt oder in der Berliner Morgenpost nachlesen. Danke auch an Dr. Rene Jackstadt vom DKFZ Deutsches Krebsforschungszentrum in Heidelberg, der über den Einsatz des #ReverseClinicalEngineerings sagt, dass es aus seiner Sicht noch keine 100-prozentige Garantie gibt. Die Schlüsselwörter sind das "noch" und die 100% Marke. 100% sind hart zu knacken, aber wir arbeiten daran! #ChallengeAccepted https://lnkd.in/gyNR_gXY

Today marks a significant milestone for #CELLphenomics as we celebrate our 10th #anniversary! Over the last ten years, we have undertaken a incredible journey of innovation. Our commitment to pushing the boundaries of scientific #research has enabled us to make significant contributions in pioneering work with #organoids. Our patient-derived cell culture models have proven to be a powerful tool in biomedical research by providing a more physiologically relevant model system for the study of human biology and cancer. At CELLphenomics, we are proud to have been at the forefront of utilizing #organoid technology to generate new insights and discoveries. None of this would have been possible without the support of our dedicated team, the trust of our customers and our valued partners. We would therefore like to thank everyone who has accompanied us on this journey! #PD3D #organoid #organoids #cancer #science #cellphenomics #laboratory #lablife #happybirthday #tumor #cancerresearch #wemakecompoundswork

Participating in the German Biotech Days was not only fulfilling work but also an immensely enjoyable experience. Being part of this dynamic platform for idea exchange and innovation promotion across various fields was truly a pleasure. We extend our gratitude to the visitors of our stand for engaging in stimulating discussions and fostering a professional exchange of ideas with our colleagues Cynthia Veronica Yapto, Dr. Ulrike Pfohl and Katja Herrera Glomm. #PD3D #organoid #organoids #wemakecompoundswork #DBT #DeutscheBiotechnologietage #DBT24 #DBT2024 #stand #booth #science #biotechnology #scientist #germany #berlin

We are pleased to announce our participation in the German Biotech Days. This event is an excellent platform to learn about the latest #advances and #collaborations that are driving the #biotech sector forward. We invite you to visit our booth to get an insight into our work and learn how #organoids are shaping the future of #cancer #research. #PD3D #cancer #research #booth #stand #DBT #DBT24 #DTB2024

#AACR24 is over and there was so much to learn and discuss. My take-aways are: 1. CELLphenomics GmbH is doing great internationally. 2. FDA is re-working #LDT approvals, which may be a hugh opportunity for ASC Oncology GmbH 3. We have some of the greatest partners, clients, colleagues, and friends in the community. 4. We need strengthening Society for Functional Precision Medicine over in Europe as strong advocate for making precision medicine really a commodity for medical teams and patients.

Congratulations to our colleague Dr. Ulrike Pfohl on winning the Science Slam in Hamburg! She presented the topic of her PhD thesis in front of 500 science enthusiasts. During her work at CELLphenomics, she discovered a biomarker that predicts drug response in colorectal cancer, which was even patented in 2021. #scienceslam #organoid #cancer #colorectalcancer #biomarker #patent #PhD #Hamburg #science #cancerresearch #research

Don't miss your opportunity to meet our CEO Christian René Alexander Regenbrecht or our Head of Laboratory Lena Wedeken at the AACR in San Diego. You can schedule your appointment here: https://lnkd.in/epHZWntW #AACR #AACR2024 #AACR24 #cancer #cancerresearch #science #cellphenomics #precisionmedicine #PD3D #organoids #organoid

Our CEO, Christian René Alexander Regenbrecht, and the Head of the Laboratory, Lena Wedeken, have arrived in San Diego to attend the AACR, which begins today. They will be presenting three posters showcasing our scientific work. „Mix and match - A comprehensive pipeline for matched patient-derived PDX and PD3D® modelsfor cancer research and preclinical drug development.“ Session: „Organoid Models of Cancer 1“ Session Date and Time: Sunday Apr 7, 1:30 PM - 5:00 PM Location: Poster Section 9 Poster Board Number: 24 „Turning data into information: Using PD3D® models to guide colorectal cancer therapy by Optim.AITM“ Session: Artificial Intelligence and Machine/Deep Learning 1 Session Date and Time: Sunday Apr 7, 1:30 PM - 5:00 PM Location: Poster Section 37 Poster Board Number: 6 „PD3D®models as jacks-of-all-trades for cancer research and therapy response prediction.“ Session „Organoid Models of Cancer 2“ Tuesday Apr 9, 9:00 AM - 12:30 PM Location: Poster Section 11 Poster Board Number: 6 If you like to meet Christian René Alexander Regenbrecht at AACR2024 in San Diego, feel free to schedule your appointment here:  https://lnkd.in/epHZWntW #AACR #AACR2024 #AACR24 #cancer #cancerresearch #science #cellphenomics #precisionmedicine #PD3D #organoids